Huntington's Disease

Huntington's disease is a hereditary neurodegenerative disease characterized by poor coordination and involuntary body movements. Discover the latest research on Huntington's disease here.

January 15, 2022
Preprint
Open Access

Mitochondrial and redox modifications in early stages of Huntington disease

BioRxiv : the Preprint Server for Biology
C. LopesAna Cristina Rego
January 15, 2022
Review

Recent advances in preventing neurodegenerative diseases.

Faculty Reviews
Shih-Ching ChouTae-In Kam
January 15, 2022

3-Hydroxykynurenine as a Potential Ligand for Hsp70 Proteins and Its Effects on Drosophila Memory After Heat Shock.

Molecular Neurobiology
Aleksandr V ZhuravlevElena V Savvateeva-Popova
January 15, 2022

Longitudinal mapping of cortical surface changes in Huntington's Disease.

Brain Imaging and Behavior
Brendan TanNellie Georgiou-Karistianis
January 14, 2022
Open Access

A novel and accurate full-length HTT mouse model for Huntington's disease.

ELife
Sushila A ShenoyChenjian Li
January 13, 2022
Review

Deep brain stimulation for chorea-acanthocytosis: a systematic review.

Neurosurgical Review
Yang WuWei Wang
January 13, 2022

Huntington's Disease Presenting as Adult-Onset Parkinsonism.

Journal of Clinical Neurology
In Hee KwakYoung Eun Kim
January 12, 2022
Preprint
Open Access

Skeletal muscle regeneration is altered in the R6/2 mouse model of Huntington's disease

BioRxiv : the Preprint Server for Biology
S. HoqueRana Soylu-Kucharz
January 12, 2022

Design, Synthesis, and Structure-Activity Relationship Study of Potent MAPK11 Inhibitors.

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Mengdie GongShiliang Li
January 12, 2022
Review

Glutathione in Brain Disorders and Aging.

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Igor Y IskusnykhDhruba Pathak
January 12, 2022

Possibilities and challenges of small molecule organic compounds for the treatment of repeat diseases.

Proceedings of the Japan Academy. Series B, Physical and Biological Sciences
Kazuhiko Nakatani
January 10, 2022

Timing of selective basal ganglia white matter loss in premanifest Huntington's disease.

NeuroImage. Clinical
Paul ZeunTrackOn-HD and HD-YAS Investigators
January 10, 2022
Review

The key players of parthanatos: opportunities for targeting multiple levels in the therapy of parthanatos-based pathogenesis.

Cellular and Molecular Life Sciences : CMLS
Libo LiuRuoxi Wang
January 11, 2022
Review

The Role of Junctophilin Proteins in Cellular Function.

Physiological Reviews
Stephan E Lehnart, Xander H T Wehrens
January 11, 2022
Open Access

Liraglutide Improves Cognitive and Neuronal Function in 3-NP Rat Model of Huntington's Disease.

Frontiers in Pharmacology
Samar M ShawkiHanan S El-Abhar
January 11, 2022
Open Access

Targeted Genetic Reduction of Mutant Huntingtin Lessens Cardiac Pathology in the BACHD Mouse Model of Huntington's Disease.

Frontiers in Cardiovascular Medicine
Saemi ParkChristopher S Colwell
January 11, 2022
Review

The Efficacy and Safety of Pridopidine on Treatment of Patients with Huntington's Disease: A Systematic Review and Meta-Analysis.

Movement Disorders Clinical Practice
Moamen Mostafa AslaWalaa A Kamel
January 11, 2022

Time-to-event prediction using survival analysis methods for Alzheimer's disease progression.

Alzheimer's & Dementia : Translational Research & Clinical Interventions
Rahul SharmaRobin G Qiu

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

4H Leukodystrophy

4H Leukodystrophy involves hypomyelination with hypogonadotropic hypogonadism and hypodontia. It is also known as POLR-3 Related Leukodystrophy. 4H syndrome symptoms include delayed or abnormal puberty, issues with central nervous system signal transmission, abnormal development of teeth, and symptoms tend to progressively get worse over time. Here is the latest research on this disease.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

© 2022 Meta ULC. All rights reserved
/feed-previews/huntingtons-disease/e36429b6-8e29-4dc5-a489-43c77b4f6c4a